服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-Staphylococcus aureus Toxin A mAbs [Tosatoxumab Biosimilar] (MABL-5344) | MABL-5344 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-VEGFA mAbs [Tovecimig Biosimilar] (MABL-5345) | MABL-5345 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Lambda |
| Anti-PDGFRA/CD140A mAbs [Tovetumab Biosimilar] (MABL-5346) | MABL-5346 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-IL33 mAbs [Tozorakimab Biosimilar] (MABL-5347) | MABL-5347 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-CSF2RB/CD131/IL3RB/IL5RB mAbs [Trabikibart Biosimilar] (MABL-5348) | MABL-5348 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL13 mAbs [Tralokinumab Biosimilar] (MABL-5349) | MABL-5349 | ELISA, FACS, Functional assay, in vivo binding | G4, Lambda |
| Anti-ERBB2/CD340/HER2 mAbs [Trastuzumab Biosimilar] (MABL-5350) | MABL-5350 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-BK Polyomavirus Major Capsid Protein VP1 mAbs [Traxivitug Biosimilar] (MABL-5351) | MABL-5351 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-CD4 mAbs [Tregalizumab Biosimilar] (MABL-5352) | MABL-5352 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CTLA4/CD152 mAbs [Tremelimumab Biosimilar] (MABL-5353) | MABL-5353 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-MSTN/GDF8/GDF-8 mAbs [Trevogrumab Biosimilar] (MABL-5354) | MABL-5354 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TSLP mAbs [Tilrekimig2 Biosimilar] (MABL-5323) | MABL-5323 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-ERBB2/CD340/HER2 mAbs [Timigutuzumab Biosimilar] (MABL-5324) | MABL-5324 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-AOC3/VAP1 mAbs [Timolumab Biosimilar] (MABL-5325) | MABL-5325 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Timcevibart Biosimilar] (MABL-5326) | MABL-5326 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CEACAM6/CD66c mAbs [Tinurilimab Biosimilar] (MABL-5327) | MABL-5327 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Tiragolumab Biosimilar] (MABL-5328) | MABL-5328 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL31 (Canine) mAbs [Tirnovetmab Biosimilar] (MABL-5329) | MABL-5329 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Tislelizumab Biosimilar] (MABL-5330) | MABL-5330 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-F3/CD142 mAbs [Tisotumab Biosimilar] (MABL-5331) | MABL-5331 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn